T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$2.48B |
| 2 |
Kenvue
KVUE
|
+$1.5B |
| 3 |
Halliburton
HAL
|
+$1.12B |
| 4 |
Boeing
BA
|
+$950M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$920M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.64B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.66B |
| 4 |
Johnson & Johnson
JNJ
|
+$1.56B |
| 5 |
Amazon
AMZN
|
+$1.17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.76% |
| 2 | Healthcare | 16.83% |
| 3 | Financials | 10.91% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVRO
1951
DELISTED
NEVRO CORP.
NVRO
| $701K | ﹤0.01% |
36,429
-397,128
| -92% | -$8.47M |
|
1952
Ameresco
AMRC
$1.47B
| $696K | ﹤0.01% |
18,048
+1,179
| +7% | +$57K |
|
1953
Benchmark Electronics
BHE
$2.89B
| $696K | ﹤0.01% |
28,664
+761
| +3% | +$19.3K |
|
|
SVC
1954
Service Properties Trust
SVC
$1.06B
| $696K | ﹤0.01% |
18,077
+1,682
| +10% | +$70K |
|
1955
Ironwood Pharmaceuticals
IRWD
$674M
| $695K | ﹤0.01% |
72,107
+10,762
| +18% | +$105K |
|
1956
Ligand Pharmaceuticals
LGND
$5.76B
| $692K | ﹤0.01% |
11,522
+1,104
| +11% | +$72.7K |
|
1957
Douglas Dynamics
PLOW
$967M
| $690K | ﹤0.01% |
22,843
+508
| +2% | +$15.5K |
|
1958
CryoPort
CYRX
$766M
| $689K | ﹤0.01% |
50,234
+7,800
| +18% | +$115K |
|
1959
Newmark Group
NMRK
$2.77B
| $686K | ﹤0.01% |
106,611
+3,123
| +3% | +$21.6K |
|
|
CSR
1960
Centerspace
CSR
$939M
| $684K | ﹤0.01% |
11,345
+378
| +3% | +$23.6K |
|
1961
BancFirst
BANF
$3.89B
| $681K | ﹤0.01% |
7,847
+565
| +8% | +$53.4K |
|
|
LTC
1962
LTC Properties
LTC
$2.1B
| $680K | ﹤0.01% |
21,155
+866
| +4% | +$28.6K |
|
|
FFIC
1963
DELISTED
Flushing Financial
FFIC
| $678K | ﹤0.01% |
51,588
+3,045
| +6% | +$42.6K |
|
1964
Veracyte
VCYT
$3.42B
| $677K | ﹤0.01% |
30,286
-3,463
| -10% | -$89.1K |
|
1965
CVR Energy
CVI
$3.58B
| $671K | ﹤0.01% |
19,716
-9,639
| -33% | -$329K |
|
1966
Sotera Health
SHC
$5.43B
| $671K | ﹤0.01% |
44,763
+1,354
| +3% | +$22.8K |
|
|
ELME
1967
Elme Communities
ELME
$144M
| $670K | ﹤0.01% |
49,108
+4,448
| +10% | +$68.9K |
|
1968
Park Aerospace
PKE
$811M
| $667K | ﹤0.01% |
42,933
+2,903
| +7% | +$41.8K |
|
|
DMC
1969
Del Monte Corp
DMC
$1.44B
| $666K | ﹤0.01% |
25,770
+770
| +3% | +$20.1K |
|
1970
Five Star Bancorp
FSBC
$1.16B
| $666K | ﹤0.01% |
33,149
+270
| +0.8% | +$6.03K |
|
1971
Enterprise Financial Services Corp
EFSC
$2.4B
| $665K | ﹤0.01% |
17,733
+886
| +5% | +$35.4K |
|
1972
Trip.com Group
TCOM
$28.3B
| $662K | ﹤0.01% |
18,926
| – | – |
|
1973
Pitney Bowes
PBI
$2.28B
| $661K | ﹤0.01% |
218,765
+18,892
| +9% | +$64.7K |
|
1974
Coeur Mining
CDE
$19B
| $658K | ﹤0.01% |
296,373
+48,793
| +20% | +$127K |
|
1975
National Vision
EYE
$1.51B
| $657K | ﹤0.01% |
40,594
-20,646
| -34% | -$413K |
|
Similar funds
T. Rowe Price Associates's Q3 2023 Portfolio in Review
As of Q3 2023, T. Rowe Price Associates held 2,959 positions worth $682B, down 4.9% from $718B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.7%. T. Rowe Price Associates opened 69 new positions and exited 71, leaving the 2,959-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2023 buy was Maplebear: 6,435,942 shares worth $191M.
- T. Rowe Price Associates added most to SLB Ltd in Q3 2023, an estimated $2.48B increase.
- T. Rowe Price Associates's biggest Q3 2023 reduction was Microsoft, cutting an estimated $2.64B.
- T. Rowe Price Associates fully exited Life Storage, Inc. in Q3 2023, selling an estimated $285M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $682B portfolio in Q3 2023.
- T. Rowe Price Associates opened 69 new positions and closed 71 in Q3 2023.
- T. Rowe Price Associates's portfolio value fell 4.9% quarter-over-quarter to $682B.
Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.